AspirinIbuprofenPlatelet Aggregation InhibitorsTiclopidinePlatelet AggregationPlatelet Function TestsPurinergic P2Y Receptor AntagonistsThromboxane B2Blood PlateletsReceptors, Purinergic P2Y12Anti-Inflammatory Agents, Non-SteroidalPlatelet ActivationCyclooxygenase InhibitorsAdenosine DiphosphateDrug Therapy, CombinationThrombosisBleeding TimeDrug InteractionsCyclooxygenase 1Thromboxane A2Fibrinolytic AgentsPlatelet Glycoprotein GPIIb-IIIa ComplexThiophenesDrug ResistanceStentsDose-Response Relationship, DrugAngioplasty, Balloon, CoronaryTreatment OutcomeHemorrhagePlatelet CountAryl Hydrocarbon HydroxylasesProton Pump InhibitorsAnticoagulantsCross-Over StudiesTime FactorsP-SelectinCoronary Artery DiseaseCollagenProspective StudiesAcetaminophenAnalgesics, Non-NarcoticSalicylatesDipyridamoleWarfarinNaproxenCoronary ThrombosisCoronary DiseaseAdenosineThromboxanesDouble-Blind MethodStrokeThienopyridinesNitric OxideCyclooxygenase 2 InhibitorsRisk FactorsMyocardial InfarctionAcute Coronary SyndromeProstaglandin-Endoperoxide SynthasesDiclofenacSodium SalicylateGastrointestinal HemorrhagePhenprocoumonTablets, Enteric-CoatedAdministration, OralIndomethacinSulfinpyrazonePostoperative HemorrhageThromboembolismFollow-Up StudiesSecondary PreventionDrug Administration ScheduleRandomized Controlled Trials as TopicAntipyreticsCyclooxygenase 2HeparinDrug-Eluting StentsAsthma, Aspirin-InducedEpoprostenolPremedicationRisk AssessmentRecurrenceLactonesDuctus Arteriosus, Patent6-Ketoprostaglandin F1 alphaTetrazolesProstaglandinsCerebrovascular DisordersCardiovascular DiseasesStomach UlcerDinoprostoneIschemic Attack, TransientKetoprofenDrug CombinationsThrombelastographyArachidonic AcidTherapeutic EquivalencyRetrospective StudiesSulfonesBrain IschemiaPlatelet Adhesiveness